Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.
ResMed Inc. has released its latest statement on CHESS Depositary Interests (CDIs), revealing a net decrease of 7,296,570 CDIs issued over quoted securities from the previous month due to net transfers between CDIs and common stock on the NYSE. The announcement also highlights an increase in securities issued over which CDIs have not been issued, driven by stock option exercises, restricted stock units, employee stock purchase plans, and share repurchases on the NYSE. This shift reflects strategic moves in managing equity and could impact their market positioning and shareholder value.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep disorders, particularly sleep apnea. The company is known for its innovative solutions in sleep therapy and ventilation, catering to a global market.
YTD Price Performance: 9.27%
Average Trading Volume: 885,933
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$56.68B
Learn more about RMD stock on TipRanks’ Stock Analysis page.
